The phosphorylation of proteins on tyrosine residues is essential for transmission of signals for cell growth, proliferation, and differentiation. Phosphorylation depends on a regulated balance between the activities of protein tyrosine kinases and protein tyrosine phosphatases (PTP). While the roles and the mechanisms of action of tyrosine kinases are well characterized, our present understanding of tyrosine phosphatases is less developed.
PTP are classified into two groups, one comprising cytoplasmic and the other transmembrane, or receptor type (receptor protein tyrosine phosphatases [RPTP] ), proteins. Seven different classes of RPTP have been defined, based primarily upon variations in the extracellular domain (reviewed in references 2 and 9). RPTP have one or more intracellular catalytic domains with a conserved cysteine at the active site, a transmembrane region, and an extracellular domain. We have focused our studies on RPTP␥, a receptor-type PTP containing an extracellular carbonic anhydrase domain, a fibronectin type III domain, and a spacer domain (1) . RPTP␥ is representative of a subfamily of RPTP that includes RPTP (also designated RPTP␤). As is the case for RPTP, several isoforms have been described for RPTP␥ (19) . RPTP␥-B lacks 29 amino acids in a cytosolic helix-turn-helix like motif in the juxtamembrane position compared to the full-length RPTP␥-A isoform. RPTP␥-C contains only one phosphatase domain, while RPTP␥-D is a soluble isoform and has lost all phosphatase activity.
Very few studies have reported on the biological function of RPTP␥. Overexpression of RPTP␥-A in the neuronal PC12D cell line prevented neurite outgrowth upon nerve growth factor (NGF) treatment (20) . Both interleukin 1␤ and tumor necrosis factor upregulate RPTP␥ mRNA in astrocytoma cell lines, suggesting a potential role for RPTP␥ in the development of inflammatory diseases of the brain (18) . RPTP␥ maps to chromosome 3p14.2, a locus frequently deleted in lung, renal, and early-stage breast tumors, and was thought to be a target of a translocation at 3p14 in renal cell carcinoma (10, 11) . However, other candidate tumor suppressor genes have been identified in the same chromosomal area. Still, a point mutation of RPTP␥ has been detected recently in colon cancer (27) and reduced expression of RPTP␥ has been observed in gastric cancer tissues (28) , implying a potential role in tumor suppression. The lack of tools such as specific antibodies and genetically manipulated mice models has hindered the elucidation of the roles of RPTP␥. Moreover, reports on RPTP␥ to date suggest species differences, and the exact cell types expressing RPTP␥ still await determination.
We generated an RPTP␥ knockout/␤-galactosidase (␤-Gal) knockin mouse and characterized expression of RPTP␥ and behavior of these animals. We demonstrate that RPTP␥ is expressed during embryogenesis and in adult mice in a variety of tissues. RPTP␥ is also expressed in the brain, with strong expression in pyramidal and sensory neurons. Finally, we demonstrate that RPTP␥-null mice did not show any obvious phenotype and exhibited minor behavioral changes.
MATERIALS AND METHODS
Generation of mice with a disruption of RPTP␥. The construction of the transgene and the RPTP␥-␤-Gal knockin mouse gene is shown in Fig. 1 . To generate RPTP␥-null mice, an internal ribosome entry site-␤-Gal-neomycinpoly(A) cassette was inserted into 3Ј to exon 1. Linearized vector was electroporated into W4 embryonic stem (ES) cells, and homologous recombination was confirmed by the presence of a 2.5-kb EcoRI fragment (in addition to the native 5.2-kb fragment) with Southern blot analysis using a 5Ј probe and the presence of a 6.2-kb BamHI fragment using a 3Ј probe. Two correctly targeted ES cell clones were used in embryo aggregation to generate germ line chimeras. This transgene results in the promoter of RPTP␥ driving the expression of the fusion protein between ␤-Gal and neomycin instead of RPTP␥. Wild-type and heterozygous or homozygous animals were either maintained as pure 129SvEv stock or used at a third-generation backcross to C57BL/6 for behavioral analysis.
Reverse transcription and PCR. Total RNA was prepared from RPTP␥-deficient and wild-type brains. RNA (1 g) of each genotype was incubated with or without the Moloney murine leukemia virus reverse transcriptase (Roche). PCR using primers located on the extracellular domain of RPTP␥ (forward primer, 5Ј-GCACCGAGCAAGGACAGCGAG-3Ј; reverse primer, 5Ј-GAGGA GGACGAGGCACACAAG-3Ј) was then carried out.
RPTP␥ antibodies.
Rabbit antibodies against RPTP␥ were generated against glutathione S-transferase (GST) fusion protein containing the second phosphatase domain (amino acids 1120 to 1445). Affinity purification of serum was performed using a protein A-Sepharose column. Antibodies directed against the GST moiety were then removed by passing the affinity-purified antibodies over a Sepharose-GST column.
Western blotting and immunoprecipitation. One hundred micrograms of total brain lysates was immunoprecipitated using the RPTP␥ antibodies. Following electrophoresis and blotting, the membrane was blotted with a 1/500 dilution of the RPTP␥ antibodies and revealed by enhanced chemiluminescence.
In situ hybridization. In situ hybridization was performed with an antisense RNA probe coding for the N terminus of the carbonic anhydrase domain of RPTP␥ (amino acids 1 to 832) transcribed by T3 polymerase (Roche). Embryos at different stages were frozen with an isopentane solution and sectioned at 16 m with a cryostat. Slides were fixed in 4% paraformaldehyde (PFA) for 15 min, washed in phosphate-buffered saline (PBS), and then acetylated in a solution containing 1.3% triethanolamine (Sigma), 0.2 M HCl, and 0.25% acetic anhydride for 10 min. The slides were then washed in PBS, transferred into prehybridization buffer (50% formamide (C) Reverse transcriptase PCR analysis using total RNA prepared from WT and knockout (KO) brains. PCR was carried out on RNA incubated with (WT and KO) or without (cWT and cKO) reverse transcriptase and on purified RPTP␥ cDNA (cDNA). Primers were chosen to amplify all RPTP␥ isoforms (arrows on scheme). (D) Immunoprecipitation and immunoblotting for RPTP␥ in extracts from WT, heterozygous (HET), and KO brains. Immunoprecipitation and immunoblotting were carried out using RPTP␥ antibodies directed against the C terminus of RPTP␥ (D2 domain on scheme). IgG from the immunoprecipitation is indicated. In panels C and D, base pair numbers and molecular weights, respectively, are noted at the left of blots. Expression of ␤-galactosidase in vivo. Mice or embryos were either directly frozen at Ϫ80°C or perfused in 2% PFA, 0.2% glutaraldehyde, 5 mM EGTA, and 2 mM MgCl 2 . Cryostat/vibratome sections (10 to 20 m) were fixed and incubated in X-Gal solution (1ϫ PBS, 5 mM EGTA, 2 mM MgCl 2 , 0.5 mg/ml 5-bromo-4-chloro-3-indolyl-␤-D-galactopyranoside [X-Gal], 10 mM potassium ferricyanide, and 10 mM potassium ferrocyanide) at 37°C. Slides were counterstained with 0.5% eosin or 1% neutral red.
Immunohistochemistry. Sections stained with ␤-Gal were fixed in 100% ethanol, washed in 0.1 M sodium phosphate buffer, pH 7.4, and incubated overnight at 4°C in solution A (bovine serum albumin 3%, NGS 3% in PBS) with anti-glial fibrillary acidic protein (GFAP) and anti-NeuN antibodies. After being washed, slides were incubated with secondary antibodies, Hoechst stained, and mounted. For timing experiments, sections were labeled with ␤-Gal and then fixed in acetone at Ϫ20°C and treated for bromodeoxyuridine (BrdU) staining as described previously (25) . Rabbit anti-GFAP (Dako) and mouse immunoglobulin G1 (IgG1) anti-NeuN (Chemicon) were used at 1/200. Mouse IgG1 anti-BrdU (Becton Dickinson) was used at 1/100. All secondary antibodies were used at 1/200. For cellular morphology experiments, sections of injected brains with dextran-biotin were first incubated with streptavidin-Cy3 (1/2,000; Jackson) and Hoechst in 5% NGS-0.1% Triton X-100 and then incubated with ␤-Gal solution.
Primary culture of glial cells. Newborn (P0) heterozygote cortices were dissociated in a papain solution containing L-cysteine (0.48 mg/ml; Sigma), DNase I (100 g/ml; Sigma), and papain (100 l/ml; Worthington) for 20 min at 37°C. Washed cells were plated onto poly-D-lysine-coated flasks in Dulbecco's modified Eagle's medium containing 15% heat-inactivated fetal calf serum. Medium was changed twice a week. Two weeks after plating, microglial cells and oligodendrocyte progenitors were recovered by differential shaking. The remaining cells (astrocytes) were dissociated with trypsin. Oligodendrocytes were purified of residual astrocytes by differential adhesion. Purified microglia, astrocytes, or oligodendrocyte progenitors were plated on polyornithine-coated coverslips overnight, fixed, and incubated in ␤-Gal solution for 24 h at 37°C.
Timing experiments. Pregnant females were injected with BrdU (50 mg/kg of animal weight) at 13.5 and 16.5 days of pregnancy, using the time of detection of a vaginal plug as 0.5 days. Twenty days after birth, pups were sacrificed and were stained for BrdU and ␤-Gal.
Dextran-biotin injections. Mice were placed in a stereotaxic apparatus and injected unilaterally with dextran-biotin 10,000 (Molecular Probes) in the somatosensory cortex. Two days later, mice were sacrificed and perfused. The brains were briefly postfixed and then cryoprotected in 30% sucrose and cut on a freezing microtome to 40-m sections.
Histology of the brain and spinal cord. RPTP␥-deficient and wild-type mice were perfused with sodium sulfite solution followed by 4% PFA. Paraffin sections (5 m thick) of the brains and spinal cords were labeled using the Timm staining protocol (5) or stained with hematoxylin and eosin.
Behavioral analyses. Male wild-type and knockout littermates were used for behavioral analyses. Animals were about 13 weeks old at the beginning of testing. Animals were housed in groups of two or three mice and maintained in a room with controlled temperature and light under a 12-h to 12-h light-dark cycle at 21 to 22°C, with food and water available ad libitum. Behavioral phenotyping was carried out over a period of 5 weeks, with 24 to 48 h between tests. Phenotyping included assessments of general health and basic sensory-motor functions, as well an extended test battery designed to investigate a wide range of brain functions, including basic sensory-motor abilities, circadian activity, anxiety, depression, information processing, learning and memory, and susceptibility to epileptic seizures. Detailed methods are described below. All experiments were carried out in accordance with the European Communities Council Directive of 24 November 1986.
Detailed methods of behavioral analyses. To assess general health and basic sensory-motor functions, each mouse was transferred into a new cage and careful preliminary observations using a modified version of standard procedures for behavioral phenotyping of genetically modified mice were performed (Irwin screen [7b] and SHIRPA [7a] ). General health was evaluated by measuring body weight, body temperature, and overt behavioral signs. Sensory functions were evaluated by measuring or scoring visual ability, audition, olfaction, tactile perception, and vestibular function. Visual ability was assessed as orientation responses to an object (a white cotton swab) being moved in each peripheral visual field at a distance of 5 cm. Auditory function was evaluated by scoring Preyer and startle reflexes (pinna flicking backwards, startle) to 90-dB click noise of 20-kHz frequency and acoustic startle. Olfaction was evaluated by scoring olfactory exploration of an object (a cotton swab) presented in front of the animal's muzzle. Tactile perception was evaluated by scoring the mouse reaction to tail or toe pinch. Motor functions were evaluated by the use of specific tests, including rotarod, string, and grip tests, as well as by measure of spontaneous locomotor activity. For the rotarod test, mice were given three trials separated by 5-to 10-min intervals during which the speed of rotation accelerated from 4 to 40 rpm in 5 min. The string test involved a wire stretched horizontally 40 cm above a On each trial the forepaws of the animal were placed on the thread, and the latency the animal took to catch the wire with its hindpaws was recorded (13a). For the grip test, each mouse was subjected to two trials separated by 5-to 10-min intervals. When the animal was holding the grid with its all paws, it was slowly moved backwards until it released it. A dynamometer recorded the maximal strength generated. Pain sensitivity was measured by tail flick, hot plate, and shock threshold. Tail flick was assessed in three consecutive trials with an interval of about 1 min (performed at different sites of the tail). For each trial, the tail of the animal was placed under a heat source. The time taken by the animal to flick its tail was recorded (cutoff, 20 s). For the hot plate test, mice were placed into a glass cylinder on a hot plate adjusted to 52°C and the latency of the first reaction (licking, moving the paws, or little leaps) was recorded. The test was ended if the mouse failed to show any sign within 30 s in order to avoid potential tissue injury. For shock threshold, mice were placed in a fear-conditioning chamber and allowed to habituate for 30 s. Foot shock was then manually applied for 1 s, and behavioral responses were noted. Shock levels began at 0.05 mA and increased in 0.05-mA steps with 30-s intervals between shocks, until both flinch (any detectable response) and vocalizations were induced. After this point, shocks were increased in 0.1-mA steps until a jump was induced. A 1-mA cutoff was employed in this test. Circadian activity was analyzed. Spontaneous locomotor activity was measured using boxes equipped with infrared analyzers allowing measurement of ambulatory locomotor activity and rears. Mice were tested for 32 h in order to measure habituation to the apparatus as well as nocturnal and diurnal activities.
Anxiety and depression measures were carried out and included light-dark exploration, open field, and tail suspension. For light-dark exploration, an apparatus consisting of dark and illuminated chambers with an interconnecting dark tunnel was used (Imetronic). The test was initiated by placing the mouse in the dark chamber. The latency to enter and amount of time spent in the lit chamber, the number of transitions between the two chambers, and locomotor activity and rearings in each chamber were recorded over a 5-min period. For the open field test, mice were tested in automated open fields (Panlab, Barcelona, Spain), placed in a room homogeneously illuminated at 150 lux. The open-field arena was divided into central and peripheral regions. Mice were placed in the periphery of the open field and allowed to explore freely for 30 min, with the experimenter out of the animal's sight. The distance traveled, the number of rearings, and time spent in the central and peripheral regions were recorded over the test session. The latency and number of crosses into as well as the percent time spent in center area were used as indices of emotionality/anxiety. For tail suspension, mice were tested in an automated tail suspension device (MED Associates Inc., St. Albans, Vt.). Immobility time was monitored through 6-min period in blocks of 2-min intervals. Latency to first immobilization was also determined.
Sensorimotor gating was then analyzed. Acoustic startle reactivity and prepulse inhibition of startle were assessed in a single session using standard startle chambers (SR-Lab Startle Response System; San Diego Instruments). Ten different trial types were used: acoustic startle pulse alone (120 dB); eight different prepulse trials in which either 70-, 80-, 85-, or 90-dB stimuli were presented alone or preceding the pulse; and finally one trial (NOSTIM) in which only the background noise (65 dB) was presented to measure the baseline movement in the Plexiglas cynlinder. In the startle pulse or prepulse-alone trials, the startle reactivity was analyzed, while in the prepulse plus startle trials the amount of prepulse inhibition was measured and expressed as a percentage of the basal startle response.
Learning and memory were assessed in a Y maze and in a Pavlovian fearconditioning model. The Y maze consisted of three arms (40 by 9 by 16 cm) placed 120°from each other. Each arm had walls with unique patterns. Mice were placed at the end of one arm with the head directed to the walls and allowed to explore the apparatus freely for 5 min. Alterations were operationally defined as successive entries into each of the three arms. Percent spontaneous alternation performance was defined as the ratio of actual (total alternations) to possible alternations (total arm entries Ϫ 2) ϫ 100. We scored alternate-arm returns and same-arm returns for each animal in order to assess aspects of attention within spontaneous working memory (26a). Total entries and the latency to exit the starting arm were also scored as an index of ambulatory activity and emotionality in the Y maze, respectively. For Pavlovian fear conditioning, four identical polymodal operant chambers (Coulbourn Instruments, Allentown, PA) were used. Each chamber (18.5 by 18 by 21.5 cm) consisted of aluminium side walls and Plexiglas rear and front (the door) walls. A loudspeaker and a bright light were inserted in the opposite side walls and constituted the sources of the cues during conditioning and cue testing. The general activity of animals was recorded through the infrared cell placed at the ceiling of the chambers and was directly recorded on a computer using Graphic State software (Coulbourn). For conditioning, mice were allowed to acclimate for 4 min, and then a light/tone (10-kHz) conditioning stimulus (CS) was presented for 20 s and coterminated by a mild (1-s, 0.4-mA) footshock (US). Two minutes later another CS-US pairing was presented. Two minutes later, mice were returned to their home cages. Testing was performed 24 h following the conditioning session. Testing for the context was performed in the morning. The mouse was placed back into the same chamber that was used for the conditioning and allowed to explore for 6 min without presentation of the light/auditory CS. Testing for the cue was performed in the afternoon (about 5 h after the context testing). The contextual environment of the chambers was changed (wall color, odor, and floor texture). The mouse was placed in the new chamber, allowed to habituate for 2 min, and then presented with light/auditory cues for 2 min. This sequence was repeated once again.
Sensitivity to pentylene-tetrazol-induced seizures was then analyzed. Pentylene tetrazol was dissolved in saline (0.9% NaCl) and injected intraperitoneally at 50 mg/kg of body weight. Immediately after injection, the mouse was placed into a new cage and observed for at least 20 min. The seizure profile (myoclonic, clonic, or tonic) as well as the latency and duration of clonico-tonic seizure was scored.
For quantitative parameters showing normal distribution, data were analyzed using an unpaired Student t test or repeated-measure analysis of variance with one between factor (genotype) and one within factor (time). Qualitative parameters (e.g., seizure profile and some of clinical observations) were analyzed using a C 2 test. The level of significance was set at P Ͻ 0.05. (24), we generated ␤-Gal knockin/RPTP␥ knockout mice, with the RPTP␥ promoter controlling expression of a ␤-Gal/neomycin resistance fusion protein (Fig. 1A) . Southern blot analyses using both the 5Ј probe and the 3Ј probe demonstrated appropriate homologous recombination (Fig. 1B) . Northern blot analysis, using a probe corresponding to the region encoding the RPTP␥ membrane-proximal phosphatase domain, revealed no detectable levels of RPTP␥ mRNA in the homozygous mutant brain (data not shown). To ensure that all four isoforms of RPTP␥ were deleted, PCR analysis with primers that amplify all four isoforms was carried out (Fig. 1C) . Appropriately sized product was observed with RNA derived from the wild-type brain but not the knockout brain. Finally, no RPTP␥ protein was detected in brains of RPTP␥-null mice by immunoblot analysis with anti-RPTP␥ antibodies developed against the C terminus (D2 domain) of RPTP␥ (Fig. 1D) . These antibodies recognize RPTP␥-A and RPTP␥-B. These results confirm the generation of an RPTP␥-null animal.
RESULTS

Generation of RPTP␥ knockout mice. Since RPTP␥ functions in ES cells
RPTP␥ knockout mice appeared grossly normal at birth. In an analysis of 263 pups from multiple matings of heterozygous knockout mice, 66 were wild-type mice, 147 were heterozygous mice, and 50 were RPTP␥-null mice. The slight reduction in the number of knockout animals (19.4% of the total) was not statistically significant.
RPTP␥ is expressed in the central nervous system (CNS).
The introduction of ␤-Gal knockin under the control of the RPTP␥ promoter permits a detailed analysis of the expression of patterned RPTP␥. To first confirm that ␤-Gal expression corresponds to RPTP␥ localization, we compared the staining obtained by in situ hybridization with a probe for the N-terminal domain of RPTP␥ (present in all RPTP␥ isoforms) to ␤-Gal staining of sagittal sections from both a heterozygous embryo at embryonic day 14.5 (E14.5) and a heterozygous brain at day 2 after birth (P2). The patterns of expression appeared identical ( Fig. 2A) , demonstrating that ␤-Gal expression in these mice is a reliable indicator of RPTP␥ expression.
During embryonic development, ␤-Gal activity was first localized in the somites and the nose at E10.5 ( Fig. 2B) . At both E10.5 and E12.5, distinct labeling of the vascular system of the brain was observed (Fig. 2B) . The isthmus, a constriction that separates the mesencephalon from the telencephalon, was (Fig. 2B ), but there was no labeling of cells in the neural tube (data not shown).
In serial sections of E14.5 and E17.5 embryos, we detected ␤-Gal in the diencephalon and mesencephalon, pons, and medulla oblongata and, later, in the telencephalon (Fig. 2C) . The peripheral nervous system was also labeled, and we clearly detected strong expression of RPTP␥ in dorsal root ganglia (DRG).
In the adult, most of the structures rich in neurons, including the cortex, the pyramidal fields (CA1, CA2, and CA3) of the hippocampus, the thalamus, and the hypothalamus, appeared positive for ␤-Gal. No ␤-Gal staining was detected in the striatum, the corpus callosum, or the subventricular zone (Fig. 2D) , regions rich in glia. In the spinal cord, expression in neonates was seen in both the dorsal and ventral horns but was confined in the adult to the dorsal horns (Fig. 2E) .
RPTP␥ is expressed predominantly in neurons. The expression of RPTP␥ corresponded closely to staining with cresyl violet, which labels the Nissl bodies of neurons ( Fig. 3A and  B) . Further immunohistochemical studies using NeuN and GFAP as specific markers for nuclei of neurons and astrocytes, respectively, showed that cells expressing ␤-Gal were all NeuN positive in the hippocampus and in the piriform cortex, indicating that RPTP␥ is strongly expressed in neuronal cells (Fig.  3A, insets) . The strong expression in neurons may mask RPTP␥ expression in other cell types. To address this point, primary cultures were prepared from cortices of newborn heterozygous RPTP␥ knockout mice, and astrocytes, microglia, and oligodendrocytes were purified and examined for ␤-Gal expression. Microglia showed weak ␤-Gal expression after 12 h of incubation with substrate, while only a small fraction of the oligodendrocytes stained for ␤-Gal (Fig. 3C) . No expression of RPTP␥ was detected in astrocytes (Fig. 3C) .
To determine which cortical layers express RPTP␥, we used a birth-dating method, administering BrdU to pregnant females at different stages of cortical neurogenesis. BrdU was injected at E13.5 and E16.5, the days of neurogenesis of the majority of neurons of layers V and II, respectively. After injections at E16.5, 87.1% of the BrdU-positive cells also contained ␤-Gal, and when injected at E13.5, 93% of the BrdUpositive cells were positive for ␤-Gal (Fig. 4A) . This indicated that the RPTP␥ is expressed in cortical layers II and V, two layers rich in pyramidal neurons. ␤-Gal expression levels in layers II and V appeared to vary across the anterior-posterior axis (increasing and decreasing gradients, respectively). To confirm expression in pyramidal cells, we injected dextranbiotin to retrogradely label pyramidal cells that have long projecting axons to the ipsilateral and contralateral cortices (Fig.  4B, right) . Retrogradely labeled pyramidal cells showed ␤-Gal staining. In addition, neutral red counterstaining showed that cells with a pyramid-like morphology were positive for ␤-Gal (Fig. 4B, left) .
RPTP␥ is expressed in sensory neurons and in sensory organs. In the CNS, ␤-Gal staining was observed to occur in major regions of sensory neurons, including nuclei of cranial nerves that innervate different sensory organs (including the ear, the tongue, the eye, the vibrissae, the olfactory bulb, and the nasal cavity). We detected clear expression of ␤-Gal in the ganglion cells of the retina, the cells of the glomerulus of the olfactory bulb, the surface of the tongue, the sensory and epithelial cells of the ear, the nasal cavity, and the follicles of the vibrissae (Fig. 5) . Among the cranial nerves, we observed (Fig. 5) . These nerves correspond predominantly to sensory nerves, i.e., nerves that are exclusively sensory (I, smell; II, vision; and VIII, balance and hearing), as well as nerves that contain both sensory and motor fibers (V, VII, and IX). The particularly strong stain in the sensory organs suggests a potential role of RPTP␥ in sensitive perception. RPTP␥-null mice do not exhibit gross neuropathological abnormalities. The general morphology and histology of brains of 2-month-old RPTP␥-null mice appeared normal. To test whether RPTP␥-deficient mice had connectivity defects, we analyzed the pyramidal cells of the hippocampus, where RPTP␥ is highly expressed, in relation to axonal projections, the mossy fibers. We used Timm staining, which specifically reveals mossy fibers and their synaptic extensions, and observed that hippocampal sections derived from wild-type and knockout mice were comparable (Fig. 6A) . Since RPTP␥ is expressed in cortical neurons, we compared the lamination and organization of the cortices. The number of cells and the organization were similar for wild-type and RPTP␤-deficient mice, demonstrating that RPTP␥ is apparently not necessary for cortical-neuron migration (data not shown). Furthermore, the overall structure of the spinal cord appeared normal (Fig. 6B) .
RPTP␥-deficient mice show modest behavioral changes. In terms of general health and sensory-motor functions, RPTP␥-null mice displayed slightly lower body weights than the wildtype littermates (P ϭ 0.05) ( Table 1) , but all of the other traits of general health were normal. We investigated potential behavioral abnormalities resulting from RPTP␥ gene disruption. For this purpose, heterozygous mice after three generations of backcross to C57BL/6 were mated, and wildtype and RPTP␥-null littermates (to control for genetic background) were tested in an extended test battery designed to investigate a wide range of brain functions, including basic sensory-motor abilities, circadian activity, anxiety, depression, information processing, learning and memory, and susceptibility to epileptic seizures.
RPTP␥-null mice also showed significant motor deficits, as revealed by the rotarod and string tests, although their muscle Table 1 ). The knockout mice had reduced latencies in the tail flick test (Table 1) ; however, they had normal pain sensitivity in the hot-plate test and normal shock threshold. Electromyograph recording revealed that knockout mice had normal nerve conduction velocity and normal compound muscle action potentials evoked by sciatic nerve stimulation (Table 1) .
In analyses of circadian activity, knockout mice showed nor- mal circadian rhythm compared to their wild-type littermates, and for both genotypes spontaneous activity (ambulatory locomotion and rears) was markedly increased during the dark phase and reduced during the light phase (data not shown). Knockout mice also showed normal habituation to the novel environment, with both wild-type and knockout animals displaying a higher level of locomotor activity and rears at the beginning of testing, which rapidly decreased in the same way for both genotypes (data not shown).
In order to evaluate emotional behavior, animals were tested in different experimental paradigms known to trigger distinctive types of stress and anxiety. No differences in anxiety or exploratory measures between knockout and wild-type mice were detected with the light-dark test (Table 1) . In the openfield test, locomotor activity and vertical exploratory activity were comparable between wild-type and knockout mice (data not shown). Anxiety-related parameters, such as the percentage of time spent in the central area, latency, and number of entries into this area, were also comparable between wild-type and knockout animals (data not shown). When animals were submitted to tail suspension tests, the total immobility times were not significantly different between the two genotypes (Table 1) . However, the latency to the first immobilization of knockout mice was longer than that of the wild-type littermates (Table 1) .
Mutant mice displayed normal startle response at 120 dB, and their reaction to the other acoustic stimuli used was also comparable to that of their wild-type littermates (data not shown). When the startling pulse was preceded by prepulses of increasing intensities, the amplitude of the startle response decreased significantly in both groups, reaching 65% and 86% at a 90-dB prepulse for wild-type and knockout animals, respectively (Fig. 7A) . The knockout mice showed significantly improved prepulse inhibition [F(1,15) ϭ 5.59, P Ͻ 0.05, repeated-measures analysis of variance (ANOVA)], particularly at higher prepulse intensities of 85 to 90 dB (P Ͻ 0.01; Student t test) (Fig. 7A) .
In the Y-maze paradigm, no difference in ratio of spontaneous alternation was noted between knockouts (62.0 Ϯ 2.7) and wild-type littermates (70.4 Ϯ 5.9), indicating that working memory performances were not affected in the mutants. At the same time, knockouts were more active than wild types, displaying significantly higher numbers of arm entries (wild types, 18.9 Ϯ 1.8; knockouts, 30.6 Ϯ 2.2; t15 ϭ 4.06, P Ͻ 0.01; student t test).
In the fear conditioning test, when exposed for the first time to conditioning cages, knockouts displayed significantly lower baseline levels of activity than did the wild-type littermates [F(1,15) ϭ 12.79, P Ͻ 0.01] (Fig. 7B, upper left, "Habituation"). Conditioned stimulus-unconditioned stimulus pairing induced a significant decrease in activity, which differed between wild types and knockouts (data not shown) [group ϫ period interaction: F(3,45) ϭ 25.51, P Ͻ 0.001, repeated-measures ANOVA]. Indeed, the immediate response to foot shocks of wild-type animals was more pronounced and tendencies between the two genotypes were reversed, with wild-type mice being significantly less active than the knockouts [F(1,15) ϭ 6.80, P Ͻ 0.05, repeated-measures ANOVA for the last two periods] (data not shown). When animals were reexposed in the same context 24 h after conditioning, both wild-type and knockout mice showed a significant decrease of activity compared to baseline [F Ն 40.24, P Ͻ 0.001, intragroup analysis for the last 2 min of habituation and the first 2 min of context] (Fig. 7B , upper left, "Context"). As can be seen from Fig. 7B , upper right, the levels of suppression of activity in both groups were comparable [F(1,15) ϭ 1.35, not significant]. This indicates that both wild types and mutants remembered the context where they received the shock. When animals were placed in a new context, presentation of a conditioned stimulus alone induced a clear fear reaction in both wild types and knockouts that was reflected by a marked suppression of activity (Fig. 7B,  lower left, periods 2 and 4) . However, the activity of the knockout group was lower than that of the wild-type group [F(1,15) ϭ 4.89, P Ͻ 0.05, repeated-measures ANOVA] (Fig. 7B, lower  right) .
When pentylenetetrazol was injected intraperitoneally at the dose of 50 mg/kg, no difference in susceptibility to seizures was observed between wild-type and knockout mice: seven out of eight animals from both genotypes had myoclonic seizures and two out of eight wild types and three out of eight knockouts had clonicotonic seizures.
DISCUSSION
Expression of RPTP␥ was detected early during development in the nervous system as well as in other organs, including intestine, kidney, testis, stomach, thymus, and vasculature. Comparison of tissue anatomies of wild-type and RPTP␥-null mice by histology did not reveal any apparent alterations. In the nervous system, the lack of apparent defects in neuronal development during embryogenesis indicates that RPTP␥ is not necessary for neural commitment. RPTP␥ expression was not detected in adult brain cells where neurogenesis occurs, indicating that RPTP␥ is not necessary for adult neurogenesis. The localization of RPTP␥ in the brain shows expression primarily in neurons, an observation confirmed by the colocalization of ␤-Gal activity and the neuronal marker NeuN. RPTP␥ is expressed particularly in cortical layers II and V, and we observed a higher density of labeled neurons in layer II, while in layer V they appeared more dispersed. This distribution is typical of the pyramidal neurons in both layers. Moreover, in the hippocampus, only the stratum pyramidale, containing the cell bodies of the pyramidal cells, is labeled. Neutral red staining and retrograde transport using dextran-biotin confirmed that RPTP␥ is expressed in the pyramidal neurons. Although we cannot exclude that other neurons are labeled with ␤-Gal in the brain, the lack of labeling in the other part of the hippocampus suggests that interneurons are not a cell population expressing RPTP␥.
One interesting comparison is with the localization of RPTP (the second member of the family), which might have been presumed to compensate for the lack of expression of RPTP␥. However, in the CNS, RPTP is strongly expressed in glial cells, astrocytes and oligodendrocytes, and in only a subset of neurons (3, 7, 21) . Moreover, it is detected primarily in the subventricular zone, the dentate gyrus, and some cells of the cortex. Thus, in the brain, RPTP␥ and RPTP appear to be expressed in different cell types and in different parts of the brain, suggesting that these two related phosphatases have different functions. (18) . It was demonstrated that RPTP is upregulated in glial cells, including oligodendrocytes and astrocytes, following injury (6, 12, 13, 15, 22) . This suggests that these two RPTP may have potentially overlapping roles in certain pathological conditions.
The Timm staining in the hippocampus did not show any apparent alteration in the development of the neurites and in branching. However, it has been reported that PC12D cells overexpressing RPTP␥-A show reduced NGF-induced neurite outgrowth (20) . We prepared DRG explants from wild-type and RPTP␥-deficient E12.5 and E14.5 embryos and followed neurite outgrowth for 24 h after NGF addition. Whether cultured on collagen-or poly-D-lysine-coated dishes, DRG explants deficient in RPTP␥ develop normally, demonstrating that RPTP␥ is not required for NGF-induced neurite outgrowth.
Surprisingly, we did not detect any expression of RPTP␥ in the motor neurons of the spinal cord, in contrast to what has been described for the chick (4) . It has been shown that RPTP is also expressed differently in Xenopus laevis, the chick, and the mouse (4, 8, 23) .
RPTP␥ is localized in sensory organs, in particular, in the cells that transform or transmit external stimuli to chemical signals. These cells include the ganglion cells of the retina, the sensory cells of the ear, the papillae of the tongue, the vibrissae of the nose, and the olfactory cells. We do not know yet which type of molecules could be regulated by RPTP␥. Ion channels have been shown to be regulated by phosphorylation and by PTP. For example, PTP␣ (26) and PTPε (14) can regulate the activity of potassium channels, and RPTP has been described as regulating a sodium channel (16, 17) . Further studies will be needed to test whether RPTP␥ regulates similar signaling pathways in these different cells to accomplish such functions.
RPTP␥-null mice had normal circadian activity. Mutants displayed specific motor deficits in the rotarod and string tests and reduced latency to react in the tail flick test. Analysis of emotional behavior showed that knockout mice had levels of anxiety and despair behavior comparable to those of wild-type littermates. Cognitive tests revealed that mutant mice showed significant enhancement of sensory processing for acoustic stimuli and reduced performance with cued fear conditioning. Working memory performance and contextual fear response were comparable to levels for wild-type littermates. Finally, knockout mice did not show altered susceptibility to pentylenetetrazol-induced seizures.
The interpretation of the subtle behavioral changes is not simple. The deficits determined by the rotarod and string tests may reflect alterations in balance or motor coordination and in traction force. It is possible that alterations in the cranial nerve, particularly the one involved in the vestibulocochlear system, may partially account for these deficits. Similarly, the enhanced prepulse inhibition may involve alterations to this system. The differential sensitivities to pain, as measured by the tail flick and hot-plate tests, suggest that while the supraspinal response to pain is grossly normal, there are differences in the spinal responses, perhaps related to the expression of RPTP␥ in the dorsal spine and the dorsal root ganglia.
In summary, we have carried out detailed expression and behavioral analyses of RPTP␥-null mice. RPTP␥ is a member of a family of phosphatases that also includes RPTP. Yet, our study makes a clear demarcation between these two phosphatases, with RPTP␥ showing expression in pyramidal and sensory neurons and RPTP showing expression in glial cells. Further characterization of RPTP␥ knockouts in specific paradigms and in specific cells will lead to a better understanding of the regulatory role of this phosphatase. Furthermore, studies of nonneuronal cells and particularly of the colon, where RPTP␥ appears to play a role in malignancies, are now feasible.
